fidaxomicin
An 18-membered macrolide that is a fermentation product obtained from the Actinomycete Dactylosporangium aurantiacum. A narrow spectrum antibiotic used for treatment of Clostridium difficile-related infections.
Classification
macrocyclic antibioticARO:3001318
-
CHEBI:24400 - macrolide antibiotic
CHEBI:25105 -
CHEBI:33308 -
CHEBI:33853 -
CHEBI:36683 - macrocyclic antibiotic
ARO:3001318
Chemical structure
| Molecular formula | C52H74Cl2O18 |
|---|---|
| Charge | 0 |
| Average mass | 1058.052 Da |
| Monoisotopic mass | 1056.42522 Da |
| Source | ChEBI |
| InChIKey | ZVGNESXIJDCBKN-KFGPIHIUSA-N |
CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)O[C@H]1[C@H](O)[C@H](OC)[C@H](OC/C2=C\C=C\C[C@H](O)/C(C)=C/[C@H](CC)[C@@H](O[C@@H]3OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]3O)/C(C)=C/C(C)=C/CC([C@@H](C)O)OC2=O)O[C@@H]1C
InChI=1S/C52H74Cl2O18/c1-13-30-22-26(6)33(56)18-16-15-17-31(23-66-51-45(65-12)42(61)44(29(9)67-51)69-49(64)35-32(14-2)36(53)39(58)37(54)38(35)57)48(63)68-34(28(8)55)20-19-25(5)21-27(7)43(30)70-50-41(60)40(59)46(52(10,11)72-50)71-47(62)24(3)4/h15-17,19,21-22,24,28-30,33-34,40-46,50-51,55-61H,13-14,18,20,23H2,1-12H3/b16-15+,25-19+,26-22+,27-21+,31-17+/t28-,29-,30+,33+,34?,40-,41+,42+,43+,44-,45+,46+,50-,51-/m1/s1
Also called
- Dificid
- Lipiarmicin
- Lipiarmycin
- OPT 80
- OPT-80
- PAR 101
- PAR-101
- Tiacumicin B
Cross-references
- fidaxomicin
ARO:3001319 - cas:873857-62-6
- reaxys:12687773
- chembl:CHEMBL1255800
- pubchem.compound:10034073
Drug registries
Patents and articles
Activity roles
- antimicrobial agent
CHEBI:33281 - antibacterial drug
CHEBI:36047
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3001319 |
fidaxomicin | antibioticmech:aro-1169c528a5 |
2026-08-30 |
| CHEBI | CHEBI:68590 |
fidaxomicin | antibioticmech:chebi-ff9b90ceb4 |
2026-08-30 |
Molecular targets
antibiotic sensitive RNA polymerase switch region PROTEIN_COMPLEX DIRECT_BINDING_TARGET
bacterial RNA polymerase PROTEIN_COMPLEX DIRECT_BINDING_TARGET
Clostridioides difficile NCBITaxon:1496
| Protein | Gene | Organism | Entry |
|---|---|---|---|
DNA-directed RNA polymerase subunit beta UniProtKB:Q18CF4 |
rpoB | Clostridioides difficile (strain 630) NCBITaxon:272563 |
REVIEWED |
DNA-directed RNA polymerase subunit beta' UniProtKB:Q18CF3 |
rpoC | Clostridioides difficile (strain 630) NCBITaxon:272563 |
REVIEWED |
Mechanism summary
- Mode of action
- NUCLEIC_ACID_SYNTHESIS_INHIBITION host shared target
Record-level evidence
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
REVIEWED
Verified exact ChEBI/CARD identity, structure, antibacterial role, class, FDA provenance, and retained CARD target assertion; curator-confirmed transcription inhibition and added the directly bound C. difficile RNAP complex.
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
CURATED_UNIPROT_PROTEIN_EXAMPLES
Added curated Clostridioides difficile strain 630 RpoB (Q18CF4) and RpoC (Q18CF3) UniProtKB protein examples on the PRIMARY_LITERATURE bacterial RNA polymerase molecular target.